Release originally posted on hlth.com
Prenosis has announced the completion of a $20M Series A financing round alongside a $20M federal contract from the Biomedical Advanced Research and Development Authority (BARDA), bringing total new funding to $40M. The Chicago-based health technology company is focused on applying artificial intelligence and biological data to improve diagnosis and treatment in critical care settings, particularly for sepsis and severe respiratory infections.
Read full release on hlth.com.